Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vyndaqel
Pharma
Pfizer's tafamidis will hold its own against new meds: analysts
Despite the arrival of potential ATTR-CM rivals from Alnylam and BridgeBio, Leerink analysts expect Pfizer's tafamidis franchise will keep growing.
Angus Liu
Sep 18, 2023 3:05pm
FDA casts doubt on Alnylam's Onpattro in ATTR-CM
Sep 11, 2023 11:15am
Pfizer sues Dexcel over proposed Vyndamax generic
Aug 14, 2023 11:40am
Pfizer prevails in proposed class action lawsuit over copays
Apr 6, 2023 11:59am
Alnylam to face FDA AdComm for Onpattro's ATTR-CM bid
Feb 21, 2023 10:53am
Pfizer sees COVID-19 product sales plummeting in 2023
Jan 31, 2023 11:26am
